BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Breast Cancer Invasive
Interventions: DRUG: Azacitidine
Sponsor: University of Illinois at Chicago